NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III Sells 12,440 Shares

NeueHealth, Inc. (NYSE:NEUE) CEO George Lawrence Mikan III sold 12,440 shares of the firm’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $6.13, for a total transaction of $76,257.20. Following the completion of the transaction, the chief executive officer now owns 249,454 shares of the company’s stock, valued at approximately $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

• On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The shares were sold at an average price of $6.93, for a total transaction of $91,337.40.
• On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total transaction of $11,324.24.
• On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
• On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $233,079.34.
• On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Stock Down 7.4 %

NEUE stock opened at $4.71 on Tuesday. The company has a 50 day moving average of $7.21 and a two-hundred day moving average of $6.01. The company has a market cap of $38.98 million, a price-to-earnings ratio of -0.09 and a beta of 0.56. NeueHealth, Inc. has a 12-month low of $3.79 and a 12-month high of $7.66.

Analysts Set New Price Targets

Separately, Royal Bank of Canada dropped their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

Institutional Trading of NeueHealth

Several hedge funds and other institutional investors have recently modified their holdings of NEUE. Partners Group Holding AG acquired a new position in NeueHealth in the 3rd quarter worth about $463,000. Virtu Financial LLC bought a new stake in shares of NeueHealth in the 4th quarter valued at approximately $76,000. Finally, Northern Trust Corp increased its holdings in NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock worth $242,000 after buying an additional 13,074 shares during the last quarter. 63.88% of the stock is currently owned by hedge funds and other institutional investors.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.